Literature DB >> 31628488

Functional cross talk between the Fanconi anemia and ATRX/DAXX histone chaperone pathways promotes replication fork recovery.

Maya Raghunandan1, Jung Eun Yeo2, Ryan Walter1, Kai Saito1, Adam J Harvey1, Stacie Ittershagen3, Eun-A Lee2, Jihyeon Yang2, Maureen E Hoatlin3, Anja K Bielinsky1, Eric A Hendrickson1, Orlando Schärer2,4, Alexandra Sobeck1.   

Abstract

Fanconi anemia (FA) is a chromosome instability syndrome characterized by increased cancer predisposition. Specifically, the FA pathway functions to protect genome stability during DNA replication. The central FA pathway protein, FANCD2, locates to stalled replication forks and recruits homologous recombination (HR) factors such as CtBP interacting protein (CtIP) to promote replication fork restart while suppressing new origin firing. Here, we identify alpha-thalassemia retardation syndrome X-linked (ATRX) as a novel physical and functional interaction partner of FANCD2. ATRX is a chromatin remodeler that forms a complex with Death domain-associated protein 6 (DAXX) to deposit the histone variant H3.3 into specific genomic regions. Intriguingly, ATRX was recently implicated in replication fork recovery; however, the underlying mechanism(s) remained incompletely understood. Our findings demonstrate that ATRX forms a constitutive protein complex with FANCD2 and protects FANCD2 from proteasomal degradation. ATRX and FANCD2 localize to stalled replication forks where they cooperate to recruit CtIP and promote MRE11 exonuclease-dependent fork restart while suppressing the firing of new replication origins. Remarkably, replication restart requires the concerted histone H3 chaperone activities of ATRX/DAXX and FANCD2, demonstrating that coordinated histone H3 variant deposition is a crucial event during the reinitiation of replicative DNA synthesis. Lastly, ATRX also cooperates with FANCD2 to promote the HR-dependent repair of directly induced DNA double-stranded breaks. We propose that ATRX is a novel functional partner of FANCD2 to promote histone deposition-dependent HR mechanisms in S-phase.
© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Year:  2020        PMID: 31628488      PMCID: PMC7206856          DOI: 10.1093/hmg/ddz250

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  61 in total

1.  XRCC3 promotes homology-directed repair of DNA damage in mammalian cells.

Authors:  A J Pierce; R D Johnson; L H Thompson; M Jasin
Journal:  Genes Dev       Date:  1999-10-15       Impact factor: 11.361

2.  Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeres.

Authors:  Peter W Lewis; Simon J Elsaesser; Kyung-Min Noh; Sonja C Stadler; C David Allis
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-22       Impact factor: 11.205

3.  Biallelic mutations in the ubiquitin ligase RFWD3 cause Fanconi anemia.

Authors:  Kerstin Knies; Shojiro Inano; María J Ramírez; Masamichi Ishiai; Jordi Surrallés; Minoru Takata; Detlev Schindler
Journal:  J Clin Invest       Date:  2017-07-10       Impact factor: 14.808

Review 4.  BRCA1 and BRCA2: different roles in a common pathway of genome protection.

Authors:  Rohini Roy; Jarin Chun; Simon N Powell
Journal:  Nat Rev Cancer       Date:  2011-12-23       Impact factor: 60.716

5.  FANCD2, FANCJ and BRCA2 cooperate to promote replication fork recovery independently of the Fanconi Anemia core complex.

Authors:  Maya Raghunandan; Indrajit Chaudhury; Stephanie L Kelich; Helmut Hanenberg; Alexandra Sobeck
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 6.  ATRX: the case of a peculiar chromatin remodeler.

Authors:  Kajan Ratnakumar; Emily Bernstein
Journal:  Epigenetics       Date:  2012-12-18       Impact factor: 4.528

7.  ATRX represses alternative lengthening of telomeres.

Authors:  Christine E Napier; Lily I Huschtscha; Adam Harvey; Kylie Bower; Jane R Noble; Eric A Hendrickson; Roger R Reddel
Journal:  Oncotarget       Date:  2015-06-30

8.  Histone H3.3 is required to maintain replication fork progression after UV damage.

Authors:  Alexander Frey; Tamar Listovsky; Guillaume Guilbaud; Peter Sarkies; Julian E Sale
Journal:  Curr Biol       Date:  2014-09-04       Impact factor: 10.834

9.  Defective FANCI binding by a fanconi anemia-related FANCD2 mutant.

Authors:  Koichi Sato; Masamichi Ishiai; Minoru Takata; Hitoshi Kurumizaka
Journal:  PLoS One       Date:  2014-12-09       Impact factor: 3.240

10.  Histone Methylation by SETD1A Protects Nascent DNA through the Nucleosome Chaperone Activity of FANCD2.

Authors:  Martin R Higgs; Koichi Sato; John J Reynolds; Shabana Begum; Rachel Bayley; Amalia Goula; Audrey Vernet; Karissa L Paquin; David G Skalnik; Wataru Kobayashi; Minoru Takata; Niall G Howlett; Hitoshi Kurumizaka; Hiroshi Kimura; Grant S Stewart
Journal:  Mol Cell       Date:  2018-06-21       Impact factor: 17.970

View more
  5 in total

1.  Fanconi anemia and mTOR pathways functionally interact during stalled replication fork recovery.

Authors:  Matthew Nolan; Kenneth Knudson; Marina K Holz; Indrajit Chaudhury
Journal:  FEBS Lett       Date:  2021-01-28       Impact factor: 4.124

Review 2.  Zebrafish Cancer Predisposition Models.

Authors:  Kim Kobar; Keon Collett; Sergey V Prykhozhij; Jason N Berman
Journal:  Front Cell Dev Biol       Date:  2021-04-27

Review 3.  Alternative Lengthening of Telomeres: Lessons to Be Learned from Telomeric DNA Double-Strand Break Repair.

Authors:  Thomas Kent; David Clynes
Journal:  Genes (Basel)       Date:  2021-10-29       Impact factor: 4.096

4.  DNAH2 facilitates the homologous recombination repair of Fanconi anemia pathway through modulating FANCD2 ubiquitination.

Authors:  Lixian Chang; Xingjie Gao; Yuxia Wang; Chunmin Huang; Min Gao; Xiaomin Wang; Chao Liu; Wenqi Wu; Wenbin An; Yang Wan; Aoli Zhang; Yingchi Zhang; Weiping Yuan; Xiaofan Zhu
Journal:  Blood Sci       Date:  2021-06-07

Review 5.  The Multiple Facets of ATRX Protein.

Authors:  Martina Valenzuela; Roberta Amato; Antonella Sgura; Antonio Antoccia; Francesco Berardinelli
Journal:  Cancers (Basel)       Date:  2021-05-05       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.